Improving viral vectors for hemophilia gene therapies by tricking the immune system - FierceBiotech

Improving viral vectors for hemophilia gene therapies by tricking the immune system  FierceBiotech

Adeno-associated virus is frequently used as a vector to deliver gene therapy, but most people are immune to it, rendering the therapy ineffective. To bypass that ...